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Introduction
Shigella species are a major cause of diarrhoea and
dysentery worldwide and are also responsible for significant
morbidity and mortality in the developing world.1,2 WHO
bulletin concluded that, 99% of the estimated 165 million
cases of Shigella diarrhoea annually occurs in developing
countries. Majority (69%) of episodes are seen in children
under five years of age.3 This is attributable to  personal
hygiene and sanitary conditions which  promote spread of
organisms like Shigella and other enteric pathogens. 
The genus is divided into four serogroups with 47
serotypes: A (S dysenteriae, 12 serotypes); B (S flexneri, 15
serotypes), C (S boydii 18 serotypes); and D (S sonnei, two
antigenic types, phase1 and phase2).4,5 This serotyping
scheme uses the polysaccharide O antigen found in the outer
part of the cell wall.
Serological analysis of Shigella has long been used
to characterize isolates for epidemiological and diagnostic
purposes.4,5 In addition, knowledge of prevalent serotype
may also assist in devising strategies such as development
of vaccine to prevent infection especially when the immuni-
ty to disease is only serotype specific.6-8 The prevalence of
a particular species of Shigella differs in various geograph-
ical areas. The WHO bulletin 1999 reported S. flexneri, the
main serogroup found in developing countries (median 60%
of isolates), followed by S. sonnei (median 15%), S. dysen-
teriae and S. boydii with equal frequency (median 6%).3
However data from Spain, Israel and the United States con-
sistently demonstrate that S. sonnei was the most common
serogroup found in industrialized countries (median 77%),
followed by S. flexneri (median 16%), S. boydii (median
2%) and S. dysenteriae (median 1%).3
Frequency of antibiotic resistance among Shigella
species is growing and has been reported in various studies
globally.9-11 Local data of antimicrobial susceptibility of
frequently used drugs like ampicillin, tetracyclines, chlo-
ramphenicol, co-trimoxazole and nalidixic acid have been
published earlier12-14 but  reports of antimicrobial suscepti-
bility to nalidixic acid, fluoroquinolones and 3rd generation
cephalosporins seems to be lacking from Pakistan. 
Studies published in Pakistan have discussed preva-
lent Shigella groups but common serotypes from different
geographic regions have not been reported.15,16 Therefore,
we conducted a study and the frequency of serogroups and
various prevalent serotypes of Shigella isolated from
Karachi, Pakistan with antimicrobial susceptibilities are
reported.
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Abstract
Objectives: To assess the frequency of serogroups and serotypes, as well as the antimicrobial susceptibility pat-
tern of Shigella species isolated from known cases of diarrhoea and dysentery from Karachi, Pakistan. 
Methods: A cross-sectional study was conducted between January 2002 and March 2003 at Aga Khan
University on stool samples received from children with diarrhoea and dysentery from four low socio-economic
areas (Sultanabad, Rehri Goth, Hijrat and Sherpao colony) of Karachi. Stool samples yielding growth of Shigella
species, were further identified for serotypes by slide agglutination. Antibiotics susceptibility was performed by
Kirby Bauer disk diffusion method. 
Results: Out of 4688 stool samples received, 193 (4.1%) were positive for Shigella species. Shigella flexneri
was the predominant serogroup (58%) followed by Shigella sonnei (16%), Shigella boydii (15%) and   Shigella
dysentriae being the least common (11%).  A number of serotypes were isolated in each serogroup, 8 serotypes
in S. flexneri, 8 serotypes in S. dysenteriae, 9 serotypes in S. boydii, and Phase 1& 2 were found in S. sonnei.
17% isolates remained non-serotypeable. All isolates were susceptible to Ofloxacin and Ceftriaxone, high rate
of resistance was observed in Cotrimoxazole (87.75%) and Ampicillin (55.5%). Emerging resistance against
Nalidixic acid (39%) was observed. 
Conclusion: Shigella still accounts for a significant proportion of bacillary dysentery in many tropical and sub-
tropical countries. Serotype identification can help in devising strategies such as development of effective vac-
cine for controlling this problem. Increasing antibiotic resistance against commonly prescribed drugs signify that
treatment options have become difficult in cases of severe dysentery (JPMA 55:184;2005).
Subjects and Methods
A cross-sectional study was conducted at the clinical
microbiology laboratory of a tertiary care hospital.  Stool
samples were collected from children with diarrhoea from
four low socio-economic areas (Sultanabad, Rehri Goth,
Hijrat and Sherpao colony) of Karachi during January 2002
to March 2003.
All submitted stool samples received in transport
media (Phosphate buffered saline) were inoculated on
MacConkey, Xylose-Lysine Deoxycholate (XLD) agar and
for enrichment in Selenite-F broth and then incubated at 37o
C for 24 hours in aerobic environment.  After overnight
incubation, Selenite-F broth was subcultured on
Salmonella-Shigella agar (oxoid).17 Colonies morphologi-
cally suggestive of Shigella species were identified by con-
ventional biochemical reactions (urea, citrate, triple sugar
iron, indole, motility) and slide agglutination tests using
antisera from Denka Seiken Co.Ltd, Japan. Non-serotypable
isolates were further checked by API 20 E (Bio Murex,
France).
Antibiotics susceptibility was performed by Kirby
Bauer disk diffusion method, against Ampicillin (10ug),
Chloramphenicol (30ug), Ceftriaxone (30ug),
Cotrimoxazole (25ug), Nalidixic acid (30ug) and Ofloxacin
(5ug).18 Statistical analysis was done using SPSS version
10.0 for Windows. 
Results
During the study period, 4688 stool samples were
received and 193 samples were found to be positive for
Shigella species giving the isolation rate of 4.1%.  Shigella
flexneri was the most predominant serogroup (58%) fol-
lowed by Shigella sonnei (16%), Shigella boydii (15%) and
Shigella dysentriae being the least common isolate (11%).
Isolation rate of Shigella  flexneri from Hijrat colony (68%)
was significantly more compared to other areas  (P value
0.001), isolation of all other serogroups from all areas did
not show any significant difference (Table 1).
Amongst S. flexneri, 8 serotypes with multiple sub-
serotypes were found, the commonest being S. flexneri type
1 (13%) and 2 (13%). Amongst S. dysenteriae 8 serotypes
were identified, and the most prevalent subtype was S.
dysenteriae 7 (42%).  Nine serotypes were found in S. boy-
dii and most frequent isolate was S. boydii 2 (20%). Eighty
percent S. sonnei belonged to phase 1 (Table 2).
Thirty three isolates (17%) suggestive of Shigella by
biochemical reactions (including API 20E) and antisera
could not be further subtyped and finally remained non-
serotypable (Table 2).  
Further analysis of data demonstrated that none of
the Shigella was found resistant to ofloxacin and ceftriax-
one. Highest percentage of antimicrobial resistance was
noted against co-trimoxazole (mean 87.75% with the range
of 72-100%) and ampicillin (mean 55.5% with range of 8-
88%). Resistance against nalidixic acid and chlorampheni-
col were comparatively lower with the mean of 39% and
11.25% respectively (Figure).
On further analysis S. flexneri was found most
resistant while S. sonnei appeared to be most susceptible to
tested drugs. Amongst S. sonnei 87-100% isolates were
found susceptible to most of the antimicrobials except co-
trimoxazole in which case almost all strains demonstrated
resistance (Figure).
Discussion
Shigella still accounts for a significant proportion of
Table 1. Isolation of Serogroups from various study areas (%).
Serogroups Hijrat Colony Rehri Goth Sultanabad Sherpao Colony Total P value
Shigella flexneri 33 (68) 20 (46) 32 (61) 28 (54) 112 (58) 0.001
Shigella sonnei 7 (14) 5 (11) 7 (13)     13 (25) 31 (16) 0.26
Shigella boydii 6 (14) 10 (23) 8 (15) 5 (9) 29 (15) 0.27
Shigella dysenteriae 2 (4) 8 (18) 5 (9) 6 (11) 21 (11) 0.30
Figure.   Antimicrobial resistance (%) of various group of Shigella. 
bacillary dysentery in the developing world. During
our study period, a total of 193 Shigella species were isolat-
ed from 4688 stool samples giving the isolation rate of
4.1%, which is similar to other studies published in India
(3.2%).19,20
Analysis of our data showed that S. flexneri was the
most prevalent   serotype (58%) followed by S. sonnei
(16%).  Though it is in contrast to the finding of developed
world but is similar to that in other countries where diar-
rhoeal diseases are endemic too.21,22 
Amongst S. flexneri, multiple serotypes were isolat-
ed from clinical samples and the highest prevalence was
found to be of serotypes 1 and 2 followed by 3, 4 and 6.
However predominance of serotypes 3, 4 and 6 of S.
flexneri had not been reported earlier in Pakistan. Recently
a change in trend has also been reported from Bangladesh
and other parts of the world.22,23 These findings support the
importance of continuous monitoring of Shigella
serogroups and serotypes.
Out of 112 S. flexneri, 20  (18%) of the isolates
remained non-serotypable by antisera (Denka Seiken)
though biochemically had excellent identification profile by
API20 E.  While, it is known that isolation of rare serotypes
of Shigella particularly of flexneri is not uncommon.
Recently Talukdar24 from Bangladesh has reported the
emergence of 1c strain. Unfortunately, the antiserum of 1c
is not commercially available.  Considering the emergence
of 1c from countries like Bangladesh, there are possibilities
that these non-type-able isolates could be of 1c subtype. For
the final identification of these strains, specific antisera and
molecular methods for genotyping would be required.24
Non sero-typeable Shigella was also found among
other groups. S. boydii (8 out of 29), S. dysenteriae (2 out
of 21) and S.sonnei (3 out of 21). Unfortunately, by the rou-
tine laboratory methods these isolates remained nontypable.
All of the tested strains were isolated from cases with
dysentery, which reinforces need to have more comprehen-
sive and cost effective ways to identify these isolates in clin-
ical laboratories of developing world.  
Isolation rate of Shigella flexneri from Hijrat colony
was significantly more as compared to other areas (P value
0.001). Isolation rate of other serogroups from different
areas did not show any significant difference. Higher rate of
Table 2. Serogroups and serotypes of Shigella.
S. flexneri No. S. boydii No. S. dysentriae No. S. sonnei No.
(n=112) (n=29) (n=21) (n=31)
S.flexneri 1 15
S.flexneri 1a 2 S. boydii 1 2 S. dysentriae 1 1 S. sonnei 1 25
S.flexneri 1b 5 S. boydii 2 6 S. dysentriae 2 2 S. sonnei  2 3
S.flexneri 2 9 S.boydii 2c 1 S. dysentriae 3 1 S. sonnei non-sero-type-able 3
S.flexneri 2a 7 S. boydii 3 1 S. dysentriae 4 3 Total 31
S.flexneri 2b 6 S. boydii 4 1 S. dysentriae 7 9
S.flexneri 3 5 S. boydii 7 1 S.dysentriae 8 1
S.flexneri 3a 6 S. boydii 8 3 S.dysentriae  12 1
S.flexneri 3b 1 S. boydii 9 1 S.dysentriae 14 1
S.flexneri 3c 2 S.boydii 10 2 S.dysentriae non-
S.flexneri 4 9 S.boydii 14 3 sero-type- able 2
S.flexneri 4a 3 S. boydii  Non- Total 21









isolation of one species from one locality of same
geographic region is not unusual and this phenomenon has
already been reported earlier from Bangladesh.14
Review of available data shows a global rise in
antimicrobial resistance. Various studies from different
parts of the world reported increase in resistance among dif-
ferent species of Shigella against commonly used drugs like
ampicillin, tetracycline, chloramphenicol and co-trimoxa-
zole.13-15 This study also reveals higher rate of resistance
particularly against co-trimoxazole and ampicillin as com-
pared to the previous local report (3.5% and 7%).12,16 
Therefore, these results strongly suggest that ampi-
cillin and co-trimoxazole cannot be used as first line drugs
in cases of severe diarrhoea and dysentery in our setting.
And this inference is in accordance with the findings from
other countries where these drugs have already proven inef-
fective against S. flexneri and S. sonnei.7-9
Resistance to nalidixic acid was found among different
groups of Shigella with variable frequency. Resistance to
nalidixic acid has been reported previously form Far east9,
Santiago25 and also from neighbouring countries like
India.19,20 In this region, nalidixic acid is an inexpensive and
frequently used drug for community acquired diarrhoea. It is
sad, as acquiring resistance against nalidixic acid in a poor
country like Pakistan will make the treatment options for a
family physician more difficult and expensive. 
Fortunately, no resistance was found against third gen-
eration cephalosporins and fluoroquinolones, which is consis-
tent with the international data. It also implies that at least a few
drugs can be empirically used in seriously ill patients. 
Our results indicate that detection of a variety of
serotypes and nontypable strains highlights the need of con-
tinuous monitoring of trends of prevalent strains. We are
hoping that in future this information will facilitate the suc-
cessful development of specific vaccine against commonly
occurring strains. 
In addition, presence of a large number of nonty-
peable Shigella isolates indicate that the commercially
available typing antisera are not sufficient to recognize all
prevalent serotypes and a need for development of more
sensitive methods for Shigella typing may be required.
There is a need to establish regional or national sur-
veillance program to document the resistance rates and
trends. Moreover, these rates should be available for all
family physicians and paediatricians to ensure appropriate
use of antimicrobials. In addition, government agencies
should monitor and restrict the use of drugs by making poli-
cies, providing guidelines and also by training the health
care workers in selection of an agent.
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